Motilal Oswal S&P 500 Index Fund vs ICICI Prudential Nifty Pharma Index Fund
Motilal Oswal S&P 500 Index Fund (Direct) and ICICI Prudential Nifty Pharma Index Fund (Direct) head to head: growth of ₹100, returns across every window, risk, cost, and portfolio overlap — every figure computed from AMFI NAV history, nothing supplied by a fund house. Both are Index Funds schemes — see the best index funds for the full ranking.
Head to head
NAVs as of 23 Oct 2026
Growth of ₹100 (rebased over the selected window)
Common period 15 Dec 2022 – 22 Oct 2026, limited by ICICI Prudential Nifty Pharma Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Motilal Oswal S&P 500 Index Fund | ICICI Prudential Nifty Pharma Index Fund | S&P 500 (₹, price) | Nifty Pharma TRI |
|---|---|---|---|---|
| 15 Dec 2022 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 |
| 11 Apr 2023 | ₹102.31 | ₹96.15 | ₹104.91 | ₹96.30 |
| 07 Aug 2023 | ₹113.63 | ₹120.63 | ₹116.32 | ₹121.58 |
| 02 Dec 2023 | ₹116.66 | ₹126.22 | ₹119.15 | ₹128.04 |
| 28 Mar 2024 | ₹133.62 | ₹147.42 | ₹136.27 | ₹149.97 |
| 23 Jul 2024 | ₹141.97 | ₹160.94 | ₹144.68 | ₹164.20 |
| 18 Nov 2024 | ₹151.82 | ₹166.95 | ₹154.89 | ₹170.77 |
| 15 Mar 2025 | ₹146.83 | ₹158.24 | ₹152.49 | ₹161.92 |
| 10 Jul 2025 | ₹164.39 | ₹171.62 | ₹167.52 | ₹175.72 |
| 04 Nov 2025 | ₹183.58 | ₹173.70 | ₹186.91 | ₹178.19 |
| 02 Mar 2026 | ₹192.64 | ₹178.70 | ₹195.00 | ₹183.55 |
| 27 Jun 2026 | ₹212.74 | ₹194.22 | ₹215.98 | ₹200.08 |
| 22 Oct 2026 | ₹222.62 | ₹199.32 | ₹224.86 | ₹205.49 |
Portfolio overlap (same stocks held through more than one fund)
Some overlap is structural: SEBI defines large cap as the top 100 stocks by market capitalisation, so two large-cap funds are fishing the same pond by regulation. The bands below are measured per sleeve pairing rather than against one blanket threshold. How this is measured →
- 503 stocks only in Motilal Oswal S&P 500 Index Fund
- 0 stocks in both — 0.0% of each portfolio by weight
- 20 stocks only in ICICI Prudential Nifty Pharma Index Fund
The more the circles overlap, the more the funds hold the same stocks.
Motilal Oswal S&P 500 Index Fund and ICICI Prudential Nifty Pharma Index Fund share 0% of their equity book by weight.
| Metric | Motilal Oswal · Direct NAV ₹33.54 Very High risk Unrated | ICICI Prudential · Direct NAV ₹19.61 Very High risk ★★★★★ |
|---|---|---|
| +22.90%Best in row | +12.79% | |
| +27.65%Best in row | +19.38% | |
| +16.81% | — | |
| +20.82% | +19.27% | |
| +22.41% | — | |
| +18.41% | +21.93%Best in row | |
| +17.98% | — | |
| Risk | ||
| 15.31% | 15.14%Best in row | |
| 1.38Best in row | 0.85 | |
| 2.05Best in row | 1.22 | |
| -19.91% | -16.59% | |
| S&P 500 (₹, price) | Nifty Pharma TRI | |
| +0.66%Best in row | -0.67% | |
| 0.98 | 1.00 | |
| 99.4% | 99.2% | |
| 95.1%Best in row | 102.3% | |
| 0.64% | 0.51%Best in row | |
| ₹4,581Cr | ₹150.77Cr | |
| — | None | |
| ₹6.00K | ₹1.00K | |
| ₹500 | ₹1.00K | |
| 6% | 26% | |
| Ankush Sood · 6.5y | Nishit Patel | |
| 28 Apr 2020 | 14 Dec 2022 | |
| 503 | 20 | |
| 38.9% | 78.2% | |
| 0.2% | 0.1% | |
3 rows carry the same value for every fund — show
- 10Y return (CAGR)
- —
- 10Y rolling avg
- —
- Lock-in
- None
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.
Frequently asked questions
Which fund has delivered higher returns — Motilal Oswal S&P 500 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
Over the last 3 years, Motilal Oswal S&P 500 Index Fund returned +27.65% CAGR against ICICI Prudential Nifty Pharma Index Fund's +19.38%, computed from AMFI NAV history. Past returns don't guarantee future performance.
Which fund is cheaper — Motilal Oswal S&P 500 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
ICICI Prudential Nifty Pharma Index Fund has the lower expense ratio: Motilal Oswal S&P 500 Index Fund charges 0.64% a year against ICICI Prudential Nifty Pharma Index Fund's 0.51%. The expense ratio is deducted from the NAV daily, so a lower one compounds in the investor's favour.
Which fund is riskier — Motilal Oswal S&P 500 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
Motilal Oswal S&P 500 Index Fund has shown higher volatility (+15.31% annualized vs ICICI Prudential Nifty Pharma Index Fund's +15.14%), measured as the annualized standard deviation of daily returns over the trailing 3 years. Worst 3-year drawdown: Motilal Oswal S&P 500 Index Fund -19.37% vs ICICI Prudential Nifty Pharma Index Fund -16.59%.
Which fund manages more money — Motilal Oswal S&P 500 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
Motilal Oswal S&P 500 Index Fund is the larger fund: Motilal Oswal S&P 500 Index Fund manages ₹4,581Cr against ICICI Prudential Nifty Pharma Index Fund's ₹150.77Cr in assets. Size cuts both ways — scale lowers costs, but a very large fund can find it harder to move in and out of positions.
Are Motilal Oswal S&P 500 Index Fund and ICICI Prudential Nifty Pharma Index Fund in the same category?
Yes — both are Index Funds schemes, so their returns, risk and cost are directly comparable against the same peer set.
Figures update daily from AMFI NAV history; ratings and ranks are WealthTicker’s own — see the methodology. This is data, not investment advice.